COMMUNIQUÉS West-GlobeNewswire

Intuitive Surgical Announces Preliminary Fourth Quarter and Full Year 2017 Results

10/01/2018 - 15:05

SUNNYVALE, Calif., Jan. 10, 2018 (GLOBE NEWSWIRE) -- Intuitive Surgical, Inc. (NASDAQ: ISRG ), a global technology leader in robotic-assisted, minimally invasive surgery, today announced certain unaudited preliminary [...]

Collegium Announces Closing of Agreement to License Rights to Commercialize Nucynta Franchise

10/01/2018 - 15:01

Establishes Collegium as a leader in responsible pain management Broadens portfolio of meaningfully differentiated products Immediately accretive, accelerates time to profitability Leverages Collegium’s existing [...]

Syneos Health Releases 2018 Commercial Trends Forecast

10/01/2018 - 15:00

RALEIGH, N.C., Jan. 10, 2018 (GLOBE NEWSWIRE) -- Syneos Health TM (NASDAQ: SYNH ), the only fully integrated biopharmaceutical solutions organization combining a CRO and a CCO (Contract Commercial Organization), today [...]

CEO to Present on US Investor TV Show and at Biotech Conference

10/01/2018 - 15:00

MELBOURNE, Australia, Jan. 10, 2018 (GLOBE NEWSWIRE) -- Immuron Limited (ASX:IMC) (NASDAQ: IMRN ) (the “Company”) is pleased to advise investors that CEO Dr Jerry Kanellos, was interviewed on The RedChip Money Report US [...]

Scythian Biosciences Corp. Announces Upgrade to the OTCQB Marketplace

10/01/2018 - 15:00

TORONTO, Jan. 10, 2018 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (the " Company " or “ Scythian ”) (TSX-V: SCYB ) (Frankfurt: 9SB ) (OTCQB:SCCYF) is pleased to announce that it has been upgraded to the OTCQB [...]

Easton Pharmaceuticals Announces the Appointment of Mr. Luigi Gentile as Director and Officer to the Company

10/01/2018 - 15:00

This Board Appointment Represents the First of Several Others to Soon be Announced TORONTO, ON, Jan. 10, 2018 (GLOBE NEWSWIRE) -- Easton Pharmaceuticals Inc. (OTC PINK: EAPH ) is pleased to announce the appointment of [...]

Progressive Care Continues to Break Records with Over $20 Million in Sales

10/01/2018 - 14:31

MIAMI, Jan. 10, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB:RXMD), through its subsidiary PharmCo, LLC, is a South Florida health services organization and provider of prescription pharmaceuticals, compounded [...]

Helomics® Corporation Announces the appointment of Dr. Marc Malandro to its Advisory Board, providing strategic insights for the Skyline Medical – Helomics Joint Venture

10/01/2018 - 14:30

PITTSBURGH, Jan. 10, 2018 (GLOBE NEWSWIRE) -- Helomics® Corporation (Helomics), a privately-held, healthcare company providing personalized medicine solutions for clients in the pharmaceutical, diagnostic, and biotech [...]

SoldierStrong to Donate State-of-the-Art Exoskeleton to the South Texas Veterans Health Care System

10/01/2018 - 14:30

STAMFORD, Conn., Jan. 10, 2018 (GLOBE NEWSWIRE) -- SoldierStrong, a nonprofit organization dedicated to providing advanced medical technologies to veterans, today announced that it will be donating an EksoGT™ [...]

Marrone Bio Innovations Announces Availability of Next Generation Grandevo® WDG Bioinsecticide in California

10/01/2018 - 14:30

DAVIS, Calif., Jan. 10, 2018 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII ) (MBI), a leading provider of bio-based pest management and plant health products for agriculture, turf and ornamental and [...]

Yale Study Demonstrates Four-Fold Superiority of Academic Level Diagnostic Accuracy

10/01/2018 - 14:27

NEW HAVEN, Conn., Jan. 10, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO ), today announced preliminary data from an ongoing study on the impact of academic pathology expertise on [...]

China Food and Drug Administration (CFDA) approves Biomerica colorectal screening test to help identify the early warning signs of colorectal cancer

10/01/2018 - 14:19

IRVINE, Calif., Jan. 10, 2018 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA ) announced the China Food and Drug Administration (CFDA) approval of the EZ Detect™ colorectal screening test designed to help identify [...]

Neos Therapeutics to Present Three Posters at the Upcoming American Professional Society of ADHD and Related Disorders (APSARD) Annual Meeting

10/01/2018 - 14:00

DALLAS and FORT WORTH, Texas, Jan. 10, 2018 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (NASDAQ: NEOS ), a pharmaceutical company focused on developing, manufacturing, and commercializing innovative extended-release (XR [...]

Elite Pharmaceuticals Reports Positive Topline Results from Pivotal Bioequivalence Studies for an Extended-Release Generic

10/01/2018 - 14:00

NORTHVALE, N.J., Jan. 10, 2018 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB: ELTP ) today reported positive topline results from pivotal bioequivalence studies for an undisclosed [...]

PositiveID Announces 2017 Highlights and Projects Continued 30% Growth

10/01/2018 - 14:00

DELRAY BEACH, Fla., Jan. 10, 2018 (GLOBE NEWSWIRE) -- PositiveID Corporation (“PositiveID” or “Company”) (OTC:PSID), a life sciences company focused on detection and diagnostics, announced today 2017 highlights for its [...]

Delcath Announces Special Protocol Agreement Modification With FDA

10/01/2018 - 14:00

NEW YORK, Jan. 10, 2018 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB:DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announces that it has concluded a [...]

Vericel to Present at the 20th Annual Needham Growth Conference

10/01/2018 - 14:00

CAMBRIDGE, Mass., Jan. 10, 2018 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ: VCEL ), a leading developer of expanded autologous cell therapies for the treatment of patients with serious diseases and conditions, [...]

Atara Biotherapeutics Announces FDA Clearance to Proceed with Enrollment at U.S. Sites for Ongoing Global Phase 1 Clinical Study to Evaluate ATA188 in Patients with Progressive or Relapsing-Remitting Multiple Sclerosis

10/01/2018 - 14:00

SOUTH SAN FRANCISCO, Calif., Jan. 10, 2018 (GLOBE NEWSWIRE) -- Atara Biotherapeutics, Inc. (Nasdaq: ATRA ), a leading off-the-shelf T-cell immunotherapy company developing novel treatments for patients with cancer, [...]

Accelerate Diagnostics achieves CE-IVD milestone for severe bacterial pneumonia assay, doubles revenue for 2017 in Q4

10/01/2018 - 13:57

TUCSON, Ariz., Jan. 10, 2018 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. announced today its declaration of conformity to the European In Vitro Diagnostic Directive 98/79/EC and CE mark of its latest assay for the [...]